Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study - Archive ouverte HAL Access content directly
Journal Articles Journal of the European Academy of Dermatology and Venereology Year : 2020

Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study

(1) , (2) , (3) , (4) , (5) , (6, 7) , (8, 9) , (10) , (10) , (11) , (12) , (13) , (14)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03710096 , version 1 (30-06-2022)

Identifiers

Cite

D Schadendorf, A. Hauschild, S. Fosko, D. Zloty, B. Labeille, et al.. Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study. Journal of the European Academy of Dermatology and Venereology, 2020, 34 (9), pp.e533-e529. ⟨10.1111/jdv.16446⟩. ⟨inserm-03710096⟩

Collections

INSERM UNIV-AMU
14 View
3 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More